Measurement and uses of oxidative status

• US 8,512,548 B2
• Filed: 08/31/2012
• Issued: 08/20/2013
• Est. Priority Date: 05/18/2007
• Status: Active Grant

• Current Assignee: Caerus Biotechnologies
• Original Assignee: Luoxis Diagnostics, Inc. (Aytu Biopharma, Inc.)
• Inventors: Bar-Or, David, Bar-Or, Raphael
• Primary Examiner(s): Weber, Jon P
• Assistant Examiner(s): YAMASAKI, ROBERT J
• Application Number:
  US13/601,586
• Publication Number:
  US 20120325685A1
• Time in Patent Office: 354 Days
• Field of Search: None
• US Class Current: 205/792
• CPC Class Codes: G01N 27/26 by investigating electrochemical variables; by using electrolysis or electrophoresis
• CPC Class Codes: G01N 27/327 Biochemical electrodes , e.g. electrical or mechanical details for in vitro measurements
• CPC Class Codes: G01N 27/4168 Oxidation-reduction potential, e.g. for chlorination of water water analysis G01N33/18
• CPC Class Codes: G01N 33/50 Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q

Abstract

The present invention provides a method of determining the overall oxidative status of a body fluid or a tissue of a patient by measuring the oxidation-reduction potential (ORP) of the body fluid or tissue. The method has been found to be useful in the diagnosis, evaluation and monitoring of patients who have suffered a trauma (such as a head injury), patients suspected of being critically-ill or who are critically ill, patients who have an infection, and patients suspected of having a myocardial infarction (MI) or who have had an MI. The method has also been found useful in monitoring and evaluating exercise performance in patients. In addition, the method has been found useful in monitoring and evaluating stored blood products and patients who will receive such a product.

Claims

1. A method of evaluating a patient having a condition associated with oxidative stress in a hospital prior to discharge to determine whether the patient should be discharged from the hospital, wherein the patient has an elevated oxidation-reduction potential (ORP) relative to normal patients, the method comprising the following steps:

a. measuring the oxidation-reduction potential (ORP) of a body fluid of the patient, wherein the body fluid is plasma;

b. determining if the ORP is significantly different than the ORP of the same body fluid from normals; and

c. discharging the patient from the hospital if the ORP is not significantly elevated compared to normals.

2. The method of claim 1 wherein the ORP is measured within the 24 hours prior to discharge of the patient from the hospital.

3. The method of claim 1, wherein the ORP is measured once per day or a plurality of times per day prior to discharge.

4. The method of claim 1, wherein the step of measuring the ORP comprises contacting an ORP electrode or redox electrode with the body fluid or tissue of the patient.

5. A method of evaluating a patient having a condition associated with oxidative stress in a hospital prior to discharge to determine whether the patient should be discharged from the hospital, wherein the patient has an elevated oxidation-reduction potential (ORP) relative to normal patients, the method comprising the following steps:

a. contacting an oxidation-reduction potential (ORP) electrode or a redox electrode with a body fluid of the patient to measure the ORP of the body fluid within the 24 hours prior to discharge of the patient from the hospital, wherein the body fluid is plasma;

b. determining if the ORP is significantly elevated compared to the ORP of the same body fluid from normals; and

c. discharging the patient from the hospital if the ORP is not significantly elevated compared to normals.